DIFFERENCE A VARIANT CAN MAKE: Early in the Oxford-AstraZeneca’s South Africa 🇿🇦 trial, before #B1351 variant became dominant, the AZ vaccine had a great efficacy of 75% risk reduction of #COVID19 after a single dose! But all that disappeared once B1351 variant showed up... 🧵 pic.twitter.com/LcVcV2aVzE
— Eric Feigl-Ding (@DrEricDing) February 8, 2021
via Twitter https://twitter.com/DrEricDing
February 08, 2021 at 11:00PM
No comments:
Post a Comment